From Our Partners
Monday, July 4, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

Army Dengue Vaccine Trial Supported by State University of New York

by Global Biodefense Staff
November 28, 2012

The United States Army Medical Research Acquisition Activity (USAMRAA) is awarding a new contract in support of an experimental dengue vaccine trial to the State University of New York, Upstate Medical Center, Syracuse, NY (SUNY). 

SUNY will provide testing services on blood samples collected from human volunteers enrolled in the vaccine trial being executed by the Army’s Medical Research and Material Command and co-development partner GlaxoSmithKline Biologicals (GSK). 

Testing includes the use of a proteomics platform to identify unique protein signatures in volunteers who received various dengue vaccines as early markers of vaccine immunogenicity. Vaccine immunogenicity is a marker of how the vaccine influenced and prepared the recipient’s immune system to prevent infection or disease following natural exposure.

SUNY was cited as having unique subject matter expertise in utilization of proteomics to characterize host immune response in blood samples collected from individuals following acute dengue virus infection or vaccination with a tetravalent live attenuated dengue vaccine. Additionally GSK, the vaccine co-development partner and co-owner of the samples, endorsed SUNY as a preferred collaborator. 

The estimated contract value is $133,000.

From Our Partners
Tags: AwardsDengueMosquito-BorneVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC